| Bacterial ratchet motors R Di Leonardo, L Angelani, D Dell’Arciprete, G Ruocco, V Iebba, ... Proceedings of the National Academy of Sciences 107 (21), 9541-9545, 2010 | 739 | 2010 |
| Rebuilding the gut microbiota ecosystem A Gagliardi, V Totino, F Cacciotti, V Iebba, B Neroni, G Bonfiglio, ... International journal of environmental research and public health 15 (8), 1679, 2018 | 355 | 2018 |
| Eubiosis and dysbiosis: the two sides of the microbiota V Iebba, V Totino, A Gagliardi, F Santangelo, F Cacciotti, M Trancassini, ... New Microbiologica 39 (1), 1-12, 2016 | 342 | 2016 |
| A distinctive'microbial signature'in celiac pediatric patients S Schippa, V Iebba, M Barbato, G Di Nardo, V Totino, MP Checchi, ... BMC microbiology 10, 1-10, 2010 | 283 | 2010 |
| Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer L Derosa, B Routy, AM Thomas, V Iebba, G Zalcman, S Friard, J Mazieres, ... Nature medicine 28 (2), 315-324, 2022 | 260 | 2022 |
| Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis V Giannelli, V Di Gregorio, V Iebba, M Giusto, S Schippa, M Merli, ... World journal of gastroenterology: WJG 20 (45), 16795, 2014 | 259 | 2014 |
| Swimming with an image R Di Leonardo, D Dell’Arciprete, L Angelani, V Iebba Physical review letters 106 (3), 038101, 2011 | 252 | 2011 |
| Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade MC Andrews, CPM Duong, V Gopalakrishnan, V Iebba, WS Chen, ... Nature medicine 27 (8), 1432-1441, 2021 | 250 | 2021 |
| Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage A Fluckiger, R Daillère, M Sassi, BS Sixt, P Liu, F Loos, C Richard, ... Science 369 (6506), 936-942, 2020 | 247 | 2020 |
| Gut bacteria composition drives primary resistance to cancer immunotherapy in renal cell carcinoma patients L Derosa, B Routy, M Fidelle, V Iebba, L Alla, E Pasolli, N Segata, ... European urology 78 (2), 195-206, 2020 | 227 | 2020 |
| Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade G Ferrere, MT Alou, P Liu, AG Goubet, M Fidelle, O Kepp, S Durand, ... JCI insight 6 (2), 2021 | 173 | 2021 |
| Higher prevalence and abundance of Bdellovibrio bacteriovorus in the human gut of healthy subjects V Iebba, F Santangelo, V Totino, M Nicoletti, A Gagliardi, RV De Biase, ... PloS one 8 (4), e61608, 2013 | 150 | 2013 |
| Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer MP Roberti, S Yonekura, CPM Duong, M Picard, G Ferrere, M Tidjani Alou, ... Nature medicine 26 (6), 919-931, 2020 | 137 | 2020 |
| Bdellovibrio bacteriovorus directly attacks Pseudomonas aeruginosa and Staphylococcus aureus Cystic fibrosis isolates V Iebba, V Totino, F Santangelo, A Gagliardi, L Ciotoli, A Virga, C Ambrosi, ... Frontiers in microbiology 5, 280, 2014 | 117 | 2014 |
| Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients S Schippa, V Iebba, F Santangelo, A Gagliardi, RV De Biase, A Stamato, ... PloS one 8 (4), e61176, 2013 | 112 | 2013 |
| Gut microbiota related to Giardia duodenalis, Entamoeba spp. and Blastocystis hominis infections in humans from Côte d'Ivoire V Iebba, F Santangelo, V Totino, F Pantanella, A Monsia, ... Journal of infection in developing countries 10 (9), 1035-1041, 2016 | 102 | 2016 |
| Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment S Terrisse, L Derosa, V Iebba, F Ghiringhelli, I Vaz-Luis, G Kroemer, ... Cell Death & Differentiation 28 (9), 2778-2796, 2021 | 87 | 2021 |
| Structural variations of vaginal and endometrial microbiota: hints on female infertility L Riganelli, V Iebba, M Piccioni, I Illuminati, G Bonfiglio, B Neroni, L Calvo, ... Frontiers in Cellular and Infection Microbiology 10, 350, 2020 | 87 | 2020 |
| The microbiota in inflammatory bowel disease in different age groups. S Cucchiara, V Iebba, MP Conte, S Schippa Digestive Diseases 27 (3), 2009 | 83 | 2009 |
| Outbreak of Achromobacter xylosoxidans in an Italian Cystic fibrosis center: genome variability, biofilm production, antibiotic resistance, and motility in isolated strains M Trancassini, V Iebba, N Citerà, V Tuccio, A Magni, P Varesi, ... Frontiers in microbiology 5, 138, 2014 | 76 | 2014 |
